Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Boehringer Ingelheim and WHO Foundation Collaborate to Boost Global Healthcare Access and Suicide Prevention Efforts

(IN BRIEF) Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnerable communities in the Americas. Boehringer Ingelheim pledged $5 million to support WHO’s 2025–2028 General Program of Work … Read the full press release

EIB Global Invests €2 Million in Vaccine Development at Akagera Medicines in Rwanda

(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release

Eviden Unveils Innovative “Cloud for Clinics” Platform to Transform Healthcare in DACH Region

(IN BRIEF) Eviden, a division of the Atos Group, has unveiled its “Cloud for Clinics,” a secure and pre-integrated platform tailored for healthcare providers in Germany and the DACH region, built on Amazon Web Services (AWS). This initiative aims to … Read the full press release

University of Liverpool and Roche Diagnostics Unite to Drive Health Innovation and Address Inequalities

(IN BRIEF) The University of Liverpool has signed a Memorandum of Understanding (MoU) with Roche Diagnostics UK and Ireland to enhance research and innovation focused on improving health outcomes and addressing health inequalities. This partnership aims to align with Roche’s … Read the full press release

GSK Reports Promising Phase III Findings for Depemokimab in Treating Chronic Rhinosinusitis with Nasal Polyps

(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated a significant reduction in nasal polyp size and nasal obstruction after … Read the full press release

Roche’s Evrysdi Shows Remarkable Motor and Cognitive Outcomes in Children with SMA After Two Years of Early Treatment

(IN BRIEF) Roche has announced positive two-year data from its RAINBOWFISH study, showcasing the effectiveness of Evrysdi® (risdiplam) in treating children with spinal muscular atrophy (SMA) when administered before symptoms appear. The study revealed that most children achieved key motor … Read the full press release

Enhertu by AstraZeneca and Daiichi Sankyo Approved in China as First HER2-Directed Therapy for Metastatic Lung Cancer

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China for the treatment of patients with unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) with HER2 (ERBB2) mutations who have previously undergone systemic … Read the full press release

SGS Expands Industry-Leading PFAS Testing Services to Boost Public Health and Environmental Safety

(IN BRIEF) SGS, a leader in Testing, Inspection, and Certification, has launched the industry’s most comprehensive suite of PFAS (per- and polyfluoroalkyl substances) testing services, addressing a wide range of industries such as consumer goods, electronics, food, and the environment. … Read the full press release

New Research Links Mitochondrial Dysfunction to Crohn’s Disease, Offering Hope for Targeted Treatments

(IN BRIEF) Researchers at the Technical University of Munich have found that mitochondrial dysfunction in the intestines can trigger Crohn’s disease symptoms by disrupting the gut microbiome. This groundbreaking discovery establishes a direct link between defective mitochondria and both tissue … Read the full press release

EIB and LUMICKS Partner to Accelerate Cancer Drug Discovery with €20 Million Investment in Advanced Immunotherapy Tools

(IN BRIEF) Amsterdam-based LUMICKS has secured €20 million in venture debt from the European Investment Bank (EIB) to advance its next-generation cell avidity platform, which aims to accelerate the development of immunotherapies for cancer treatment. Supported by the InvestEU initiative, … Read the full press release

Merck Opens €290 Million Biosafety Testing Facility in Rockville to Enhance Drug Safety and Accelerate Testing Timelines

(IN BRIEF) Merck has officially opened a new €290 million biosafety testing facility in Rockville, Maryland, designed to meet the increasing global demand for biosafety testing services. This state-of-the-art facility consolidates various operations, including biosafety testing, analytical development, and cell … Read the full press release

Roche Secures CE Certification for Groundbreaking Companion Diagnostic Aiding Gastric Cancer Treatment

(IN BRIEF) Roche has announced the CE certification of its VENTANA CLDN18 (43-14A) RxDx Assay, marking a significant advancement in companion diagnostics for patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma. This diagnostic tool enables clinicians to identify patients who … Read the full press release

NIB Supports FinVector’s New Gene Therapy Facility in Kuopio to Enhance Cancer Treatment Capabilities

(IN BRIEF) FinVector, a leading biopharmaceutical company, has inaugurated a cutting-edge production facility in Kuopio, Finland, aimed at manufacturing gene therapy products. The new Finport facility, which is set to become one of the world’s largest for such therapies, represents … Read the full press release

Novo Nordisk Launches Global Childhood Obesity Initiative to Support Healthier Urban Communities

(IN BRIEF) Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children in underserved urban communities across six cities worldwide. Backed by an investment of over 250 million Danish kroner and a coalition … Read the full press release

QIAGEN and Neo4j Strengthen Partnership to Revolutionize Biomedical Data Analysis in Biopharma Industry

(IN BRIEF) QIAGEN Digital Insights has announced an expanded partnership with Neo4j, aiming to enhance biomedical data analysis for the biopharmaceutical industry. This collaboration will integrate Neo4j’s graph database and machine learning capabilities with QIAGEN’s extensive biomedical knowledge base. By … Read the full press release

Beiersdorf Sets Bold Net Zero Targets by 2045, Reinforcing Commitment to Sustainability at Hamburg Conference

(IN BRIEF) Beiersdorf, a leading skincare company, has announced its ambitious sustainability goals during the Hamburg Sustainability Conference. The company aims to achieve Net Zero emissions by 2045 and intends to reduce emissions across its entire value chain by 90%. … Read the full press release

Fabentech Secures €20 Million EIB Loan to Bolster Pandemic Preparedness and Biological Threat Response

(IN BRIEF) Fabentech, a French biopharmaceutical company, has secured a €20 million loan from the European Investment Bank (EIB) through the HERA Invest initiative. The funding will support Fabentech’s research, bioproduction, and expansion of its FabShield® technology, which focuses on … Read the full press release

Early Success: AstraZeneca’s Airsupra Proves Highly Effective in Reducing Severe Asthma Risks in Phase III Trial

(IN BRIEF) AstraZeneca’s inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk of severe asthma exacerbations in patients with intermittent or mild persistent asthma, according to high-level results from the BATURA Phase IIIb trial. The trial … Read the full press release

Breakthrough Peptide Inhibitor Targets Tau Protein Aggregation, Paving the Way for New Alzheimer’s Treatments

(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and inhibits two key aggregation-promoting hotspots of the Tau protein, which is critical … Read the full press release

EMPA Researchers Pioneering Nanoceramics for Innovative Skin Disease Treatment

(IN BRIEF) On October 1, 2024, Andrea Six reported on the groundbreaking work by EMPA researchers in collaboration with Aldena Therapeutics to develop nanoceramic “stars” for treating common skin conditions like psoriasis and neurodermatitis. These nanoceramic structures temporarily create micro-wounds … Read the full press release